Addus Homecare 2025 Q3 Earnings Strong Revenue Growth and Profitability

Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Wednesday, Nov 5, 2025 4:29 am ET1min read
Aime RobotAime Summary

- Addus Homecare’s Q3 2025 earnings surged with 25% revenue growth and 13.3% higher net income, driven by strategic acquisitions and operational efficiency.

- Despite strong revenue, the stock fell 9.78% post-earnings due to EPS shortfall and market sentiment, though analysts maintain a $141.91 average price target.

- CEO R. Allison highlighted an 18-year profitability streak and expansion via Texas-based Del Cielo, boosting personal care revenue to 75%.

- 2025 revenue guidance of $1.41B and 2026 EPS of $6.20 signal long-term growth confidence despite minor 2025 EPS cuts.

Addus Homecare (ADUS) reported robust Q3 2025 earnings, driven by a 25% revenue increase and expanded profitability. The company’s results exceeded expectations in several key areas, with management highlighting strategic acquisitions and operational efficiencies as key contributors to performance.

Revenue


Addus Homecare’s total revenue surged 25.0% year-over-year to $362.30 million in Q3 2025, reflecting strong demand across its core segments. Personal care services led the charge, generating $275.77 million in revenue, while hospice care contributed $68.89 million. The home health segment added $17.64 million, rounding out the company’s diversified revenue streams. This performance underscores the company’s ability to capitalize on market opportunities and scale operations effectively.


Earnings/Net Income


The company’s earnings per share (EPS) rose 11.5% to $1.26, compared to $1.13 in Q3 2024, while net income expanded 13.3% to $22.85 million. These results reflect disciplined cost management and operational leverage, with

maintaining profitability for 18 consecutive years in the quarter. The EPS growth, though below the $1.37 consensus estimate, highlights the company’s resilience in a competitive market.


Post-Earnings Price Action Review


Following the earnings release, Addus Homecare’s stock experienced a decline, with a 9.78% drop in the latest trading day, a 6.89% decline for the week, and a 2.30% monthly pullback. While the results beat revenue expectations, the EPS shortfall and broader market sentiment contributed to the downward pressure. Analysts remain cautiously optimistic, with price targets averaging $141.91 and a 21.61% implied upside from the current level.


CEO Commentary


R. Allison, CEO & Chairman, emphasized the company’s momentum, stating, “Our Q3 results reflect the strength of our business model and the value of our recent acquisitions. We are well-positioned to deliver sustainable growth as we expand our footprint and enhance service offerings.”


Additional News


Recent developments highlight Addus Homecare’s strategic focus on expansion and investor confidence. The company’s acquisition of Texas-based Del Cielo has accelerated growth in personal care services, which now account for over 75% of revenue. Additionally, Barclays raised its price target to $117 from $111, citing improved operational metrics and a favorable industry outlook. Analysts also noted the company’s 18-year profitability streak as a testament to its durable business model.


<img src="https://cdn.ainvest.com/aigc/hxcmp/images/compress-qwen_generated_1762334877600.jpg.png" style="max-width:100%;">

Guidance


Addus Homecare’s full-year 2025 revenue is projected to reach $1.41 billion, with earnings expected at $5.31 per share. While 2025 EPS estimates have slightly declined from $5.39 to $5.31, 2026 forecasts show optimism, with earnings estimates rising to $6.20 per share. These trends reflect confidence in the company’s long-term growth trajectory.

Comments



Add a public comment...
No comments

No comments yet